2021年美国风湿病学会幼年特发性关节炎治疗指南:非药物治疗、药物监测、免疫接种和影像学建议
该指南针对幼年特发性关节炎(JIA)的非药物治疗、药物监测、免疫接种和影像学管理提出建议,不区分JIA表型。通过系统文献回顾和GRADE方法评级证据质量(均为低或极低),投票小组(含临床医生和患者/照护者)就推荐方向和强度达成共识,超过半数推荐为条件性推荐。
要点
- 推荐使用物理治疗和作业治疗干预、健康均衡适龄饮食、特定药物实验室监测、广泛免疫接种及与患者/照护者共享决策。
- 所有推荐证据质量均为低或极低,因此超过半数推荐为条件性推荐。
- 本指南补充2019年ACR JIA和葡萄膜炎指南及同期2021年关于少关节炎、颞下颌关节炎和全身型JIA的指南。
核心结论
- 本临床实践指南为临床医生、患者和照护者提供决策支持工具,考虑关节和非关节表现严重程度及患者生活质量。
- 尽管证据质量普遍较低且许多推荐为条件性,但照护者和患者参与决策过程增强了指南的相关性和适用性。
- 这些是推荐意见,临床决策应始终由治疗临床医生和患者/照护者做出。
研究设计与样本
- 通过提出临床相关PICO问题,进行系统文献回顾,采用GRADE方法评级证据质量(高、中、低或极低)。
- 投票小组包括临床医生和患者/照护者,就推荐方向(支持或反对)和强度(强或条件性)达成共识。
主要发现
- 推荐包括使用物理治疗和作业治疗干预、健康均衡适龄饮食、特定药物实验室监测、广泛免疫接种以及与患者/照护者共享决策。
- 所有推荐证据质量均评级为低或极低。
- 超过半数的推荐为条件性推荐。
关键数值与推荐
- 所有推荐证据质量均为低或极低。
- 超过半数的推荐为条件性推荐。
临床怎么用
- 本指南为临床医生、患者和照护者提供决策支持工具。
- 临床决策应始终由治疗临床医生和患者/照护者做出。
局限性
- 所有推荐证据质量均评级为低或极低。
- 超过半数的推荐为条件性推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide recommendations for the management of juvenile idiopathic arthritis (JIA) with a focus on nonpharmacologic therapies, medication monitoring, immunizations, and imaging, irrespective of JIA phenotype. METHODS: We developed clinically relevant Patient/Population, Intervention, Comparison, and Outcomes questions. After conducting a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluation approach was used to rate the quality of evidence (high, moderate, low, or very low). A Voting Panel including clinicians and patients/caregivers achieved consensus on the direction (for or against) and strength (strong or conditional) of recommendations. RESULTS: Recommendations in this guideline include the use of physical therapy and occupational therapy interventions; a healthy, well-balanced, age-appropriate diet; specific laboratory monitoring for medications; widespread use of immunizations; and shared decision-making with patients/caregivers. Disease management for all patients with JIA is addressed with respect to nonpharmacologic therapies, medication monitoring, immunizations, and imaging. Evidence for all recommendations was graded as low or very low in quality. For that reason, more than half of the recommendations are conditional. CONCLUSION: This clinical practice guideline complements the 2019 American College of Rheumatology JIA and uveitis guidelines, which addressed polyarthritis, sacroiliitis, enthesitis, and uveitis, and a concurrent 2021 guideline on oligoarthritis, temporomandibular arthritis, and systemic JIA. It serves as a tool to support clinicians, patients, and caregivers in decision-making. The recommendations take into consideration the severity of both articular and nonarticular manifestations as well as patient quality of life. Although evidence is generally low quality and many recommendations are conditional, the inclusion of caregivers and patients in the decision-making process strengthens the relevance and applicability of the guideline. It is important to remember that these are recommendations. Clinical decisions, as always, should be made by the treating clinician and patient/caregiver.
引用
- Onel KB, Horton DB, Lovell DJ, et al. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Arthritis Rheumatol. 2022. PMID: 35233961. doi:10.1002/art.42036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。